Could Eli Lilly's Next Weight Loss Drug Waylay Wegovy -- and Even Zap Zepbound?

After stealing the show with Zepbound, Eli Lilly could further gain an edge in the market with its latest weight loss treatment, retatrutide. In recent clinical trials, the drug has demonstrated that it can serve as a stronger diabetes and weight loss treatment than its predecessors, not to mention the competition....

The Motley Fool - 5/17/2026 1:00:00 AM More News for LLY
Stock Analysis for LLY
Related Stocks: